Another more recent study demonstrated high levels of TREM2+ TAMs predicted worse overall survival in both lung adenocarcinoma and lung squamous cell carcinoma, which is also in disagreement with the pan-cancer analysis. This evidence concerns the gene TREM2 and lung adenocarcinoma.